Characteristic | Group | P value | |
---|---|---|---|
 | Repair observed | Repair not observed |  |
Patients (n) | 13 | 109 | Â |
Female (n [%]) | 10 (76.9%) | 93 (85.3%) | NSa |
Age (mean [range]; years) | 64.2 ± 9.8 (39–78) | 60.6 ± 12.6 (22–85) | NSb |
Disease duration (mean [range]; years) | 12.5 ± 9.6 (2.7–38) | 14.3 ± 10.8 (1–45) | NSc |
RF positivity (n [%]) | 11(84.6%) | 85(78.0%) | NSa |
Dosage of prednisone (mean [range]; mg) | 2.0 ± 2.1 (0.0–6.0) | 3.7 ± 3.3 (0.0–14.5) | NSc |
Prescribed bisphosphonate (n [%]) | 8 (61.5%) | 79 (72.5%) | NSa |
Functional class | |||
   I | 4 | 10 | <0.01c |
   II | 9 | 78 |  |
   III | 0 | 18 |  |
   IV | 0 | 3 |  |
RA stage | |||
   I | 0 | 0 | NSc |
   II | 4 | 36 |  |
   III | 2 | 19 |  |
   IV | 7 | 54 |  |
DAS28-3 score at baseline (mean [range]) | 4.4 ± 1.2 (2.7–6.0) | 4.0 ± 1.1 (1.0–7.0) | NSb |
DAS28-3 score at follow up (mean [range]) | 2.7 ± 1.1 (1.5–5.4) | 3.7 ± 1.2 (0.2–8.1) | <0.005b |
ΔDAS28-3 (mean [range]) | -1.7 ± 1.2 (-3.5 to +0.1) | -0.3 ± 1.0 (-2.4 to +2.6) | <0.001b |
Time interval between pairs of radiographs, years (mean [range]) | 2.3 ± 1.0 (1.4–3.1) | 1.6 ± 1.8 (1.0–1.6) | NSb |
ΔDAS28-3/year (mean [range]) | -0.9 ± 0.8 (-2.6 to +0.1) | -0.2 ± 0.9 (-2.8 to +3.4) | <0.01b |